Previous close | 141.49 |
Open | 143.13 |
Bid | 144.70 x 1200 |
Ask | 146.58 x 1200 |
Day's range | 142.35 - 151.29 |
52-week range | 119.71 - 151.73 |
Volume | |
Avg. volume | 270,346 |
Market cap | 9.737B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 30.88 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.80 (1.23%) |
Ex-dividend date | 25 Jul 2024 |
1y target est | N/A |
AptarGroup's (ATR) Q2 top line increases y/y, driven by the strong performance in the Pharma segment.
AptarGroup (ATR) delivered earnings and revenue surprises of 0.74% and 1.66%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.36 per share. The maker of consumer-product dispensing systems posted revenue of $910.1 million in the period.